[SCHEDULE 13G] WORK Medical Technology Group LTD SEC Filing
WOK: L1 Capital reports 7,897,548 shares, 9.99% stake in Class A of WORK
L1 Capital Global Opportunities Master Fund, Ltd. filed a Schedule 13G reporting beneficial ownership of 7,897,548 Class A Ordinary Shares of WORK Medical Technology Group LTD, representing 9.99% of the class.
L1 Capital Global Opportunities Master Fund, Ltd. filed a Schedule 13G reporting beneficial ownership of 7,897,548 Class A Ordinary Shares of WORK Medical Technology Group LTD, representing 9.99% of the class. The fund has sole voting and sole dispositive power over the same number of shares.
The filing notes this percentage is based on 79,054,538 Class A Ordinary Shares outstanding after the offering, as referenced in a Prospectus Supplement filed on September 26, 2025 and a Form 6-K filed on September 29, 2025. It excludes 5,102,230 pre-funded warrants due to a 9.99% beneficial ownership limitation. The certification states the securities were not acquired to change or influence control. The event date triggering the filing was September 26, 2025, and the statement was signed by Director David Feldman on October 3, 2025.
Positive
None.
Negative
None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did L1 Capital report in its Schedule 13G for WOK?
It reported beneficial ownership of 7,897,548 Class A Ordinary Shares, equal to 9.99% of the class.
How many shares of WOK were outstanding for the ownership calculation?
The percentage is based on 79,054,538 Class A Ordinary Shares outstanding after the offering, per filings on Sept 26 and 29, 2025.
Does the 13G include pre-funded warrants held by L1 Capital?
No. It excludes 5,102,230 pre-funded warrants due to a 9.99% beneficial ownership limitation.
What voting and dispositive powers did L1 Capital report?
It reported sole voting power and sole dispositive power over 7,897,548 shares.
What is the filing’s stated intent regarding control of WOK?
The certification states the securities were not acquired to change or influence control.
Who signed the Schedule 13G and when?
It was signed by David Feldman, Director, on October 3, 2025.
What class of securities is covered for WOK (ticker WOK)?
The filing covers Class A Ordinary Shares, par value $0.0005 per share.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
WORK Medical Technology Group LTD
(Name of Issuer)
Class A Ordinary Shares, par value $0.0005 per share
(Title of Class of Securities)
G9767H109
(CUSIP Number)
09/26/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
G9767H109
1
Names of Reporting Persons
L1 Capital Global Opportunities Master Fund, Ltd.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
7,897,548.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
7,897,548.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
7,897,548.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.99 %
12
Type of Reporting Person (See Instructions)
FI
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
WORK Medical Technology Group LTD
(b)
Address of issuer's principal executive offices:
Floor 23, No. 2 Tonghuinan Road, Xiaoshan District, Hangzhou City, Zhejiang Province People's Republic of China, 241003
Item 2.
(a)
Name of person filing:
L1 Capital Global Opportunities Master Fund, Ltd.
(b)
Address or principal business office or, if none, residence:
161A Shedden Road, 1 Artillery Court,
PO Box 10085
Grand Cayman, Cayman Islands KY1-1001
(c)
Citizenship:
Cayman Islands
(d)
Title of class of securities:
Class A Ordinary Shares, par value $0.0005 per share
(e)
CUSIP No.:
G9767H109
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
7,897,548
The amounts in Row (5), (7) and (9) include 7,897,548 Class A Ordinary Shares. The amounts do not include 5,102,230 pre-funded warrants to purchase Class A Ordinary Shares, which are subject to a 9.99% beneficial ownership limitation The percentage set forth on Row (11) of the cover page for the reporting person is based on 79,054,538 Class A Ordinary Shares outstanding after the offering, based on the Issuer's Prospectus Supplement filed under Rule 424(b)(5) with the Securities and Exchange Commission on September 26, 2025 and a Report of Foreign Private Issuer on Form 6-K filed with the Securities and Exchange Commission on September 29, 2025.
David Feldman and Joel Arber are the Directors of L1 Capital Global Opportunities Master Fund, Ltd. As such, L1 Capital Global Opportunities Master Fund, Ltd., Mr. Feldman, and Mr. Arber may be deemed to beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the issuer's securities described herein. To the extent Mr. Feldman and Mr. Arber are deemed to beneficially own such securities, Mr. Feldman and Mr. Arber disclaim beneficial ownership of these securities except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 13 and the rules thereunder.
(b)
Percent of class:
9.99%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
7,897,548
(ii) Shared power to vote or to direct the vote:
0
(iii) Sole power to dispose or to direct the disposition of:
7,897,548
(iv) Shared power to dispose or to direct the disposition of:
0
Item 5.
Ownership of 5 Percent or Less of a Class.
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
